IPOPLUS

1,061.4

-17.3 -1.60%

18 Jun 2026

NSE Listed · Pharmaceuticals

Zydus Lifesciences Ltd. (ZYDUSLIFE)

Volume: 39,392Avg Vol 1W: 37,776Avg Vol 1M: 1,19,99452W Range:835.51,119.8
₹1,061.4 1.60%
Market Cap₹1,11,123 Cr
Current Price₹1,061.4
Previous Close₹1,078.7
High / Low (52w)₹1,119.8 / ₹835.5
Volume39,392
Avg Vol (1W)37,776
Avg Vol (1M)1,19,994
Stock P/E19.69
Book Value₹269.5
Dividend Yield0.09%
ROE18.59%
ROA9.59%
Revenue (TTM)
Revenue Growth18.9%
Profit Margin18.86%
Total Debt₹0 Cr
Shares Outstanding101 Cr
Face Value₹1
EPS (TTM)₹12.65
P/B3.55
Debt / Equity0.46
50 DMA₹991.26
200 DMA₹924.15
Day change-1.60%
Price Chart
1,061.4 6.78% · 1Y
110686149.2L
2025-10-01
2026-06-16

20-day avg volume: 1.2L shares

Pros
  • Healthy return on equity of 18.6%.
  • Company is almost debt-free.
  • Revenue grew 19% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹7,587 Cr₹6,865 Cr₹6,123 Cr₹6,574 Cr₹6,528 Cr₹5,269 Cr₹5,237 Cr₹6,208 Cr₹5,534 Cr₹4,505 Cr₹4,369 Cr₹5,140 Cr₹5,011 Cr₹4,257 Cr₹4,135 Cr₹4,073 Cr₹3,806 Cr₹3,640 Cr₹3,760 Cr₹4,025 Cr₹3,670 Cr₹3,633 Cr₹3,659 Cr₹3,515 Cr₹3,752 Cr
EBITDA₹2,180 Cr₹1,568 Cr₹1,823 Cr₹2,005 Cr₹1,968 Cr₹1,216 Cr₹1,296 Cr₹1,932 Cr₹1,582 Cr₹945 Cr₹1,016 Cr₹1,362 Cr₹1,115 Cr₹813 Cr₹678 Cr₹718 Cr₹611 Cr₹635 Cr₹776 Cr₹782 Cr₹644 Cr₹618 Cr₹667 Cr₹640 Cr₹657 Cr
Net Profit₹1,273 Cr₹1,042 Cr₹1,259 Cr₹1,467 Cr₹1,171 Cr₹1,024 Cr₹911 Cr₹1,420 Cr₹1,182 Cr₹790 Cr₹801 Cr₹1,087 Cr₹297 Cr₹623 Cr₹523 Cr₹518 Cr₹397 Cr₹500 Cr₹3,002 Cr₹587 Cr₹679 Cr₹527 Cr₹473 Cr₹454 Cr₹392 Cr
EPS12.6510.3612.5114.5811.6410.179.0614.1111.697.87.9110.742.936.155.155.063.884.8929.325.746.645.154.624.433.83
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹23,511 Cr₹19,832 Cr₹17,424 Cr₹15,335 Cr₹14,449 Cr₹14,367 Cr
EBITDA₹6,412 Cr₹4,904 Cr₹3,324 Cr₹2,852 Cr₹2,763 Cr₹2,201 Cr
Net Profit₹4,526 Cr₹3,860 Cr₹1,960 Cr₹4,487 Cr₹2,134 Cr₹1,177 Cr
EPS44.9738.1419.343.8320.8411.49
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹37,202 Cr₹29,281 Cr₹25,756 Cr₹27,795 Cr₹23,885 Cr₹23,687 Cr
Total Liabilities₹10,843 Cr₹7,179 Cr₹6,068 Cr₹8,742 Cr₹8,955 Cr₹11,976 Cr
Equity₹26,358 Cr₹22,102 Cr₹19,688 Cr₹19,054 Cr₹14,930 Cr₹11,710 Cr
Total Debt₹0 Cr₹0 Cr₹0 Cr₹362 Cr₹610 Cr₹3,215 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹8,579 Cr₹4,514 Cr₹3,281 Cr₹2,779 Cr₹3,638 Cr₹2,808 Cr
Investing₹-8,372 Cr₹-1,475 Cr₹1,171 Cr₹1,154 Cr₹-722 Cr₹-1,012 Cr
Financing₹2,014 Cr₹-1,810 Cr₹-4,400 Cr₹-868 Cr₹-2,549 Cr₹-1,094 Cr
Free Cash Flow₹8,579 Cr₹4,514 Cr₹3,281 Cr₹2,779 Cr₹3,638 Cr₹2,808 Cr
Shareholding
Promoter 75% Institutions 18.15% Public 6.86%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search